JPH0691818B2 - Method for producing neopullulanase by transformed Bacillus subtilis - Google Patents
Method for producing neopullulanase by transformed Bacillus subtilisInfo
- Publication number
- JPH0691818B2 JPH0691818B2 JP5085761A JP8576193A JPH0691818B2 JP H0691818 B2 JPH0691818 B2 JP H0691818B2 JP 5085761 A JP5085761 A JP 5085761A JP 8576193 A JP8576193 A JP 8576193A JP H0691818 B2 JPH0691818 B2 JP H0691818B2
- Authority
- JP
- Japan
- Prior art keywords
- neopullulanase
- enzyme
- bacillus subtilis
- hind iii
- starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108010035855 neopullulanase Proteins 0.000 title claims description 23
- 244000063299 Bacillus subtilis Species 0.000 title claims description 18
- 235000014469 Bacillus subtilis Nutrition 0.000 title claims description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims description 14
- 108020004414 DNA Proteins 0.000 claims description 11
- 239000012634 fragment Substances 0.000 claims description 9
- 108091008146 restriction endonucleases Proteins 0.000 claims description 6
- 108020004511 Recombinant DNA Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 description 30
- 108090000790 Enzymes Proteins 0.000 description 30
- 229940088598 enzyme Drugs 0.000 description 30
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 22
- 229920002472 Starch Polymers 0.000 description 17
- 239000008107 starch Substances 0.000 description 17
- 235000019698 starch Nutrition 0.000 description 17
- 239000013612 plasmid Substances 0.000 description 16
- 239000004373 Pullulan Substances 0.000 description 15
- 229920001218 Pullulan Polymers 0.000 description 15
- 235000019423 pullulan Nutrition 0.000 description 15
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 13
- 108090000637 alpha-Amylases Proteins 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 9
- ZCLAHGAZPPEVDX-UHFFFAOYSA-N D-panose Natural products OC1C(O)C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC1COC1C(O)C(O)C(O)C(CO)O1 ZCLAHGAZPPEVDX-UHFFFAOYSA-N 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- ZCLAHGAZPPEVDX-MQHGYYCBSA-N panose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ZCLAHGAZPPEVDX-MQHGYYCBSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 8
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 102000004139 alpha-Amylases Human genes 0.000 description 7
- 229940024171 alpha-amylase Drugs 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 238000012258 culturing Methods 0.000 description 5
- 229920000858 Cyclodextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000001116 FEMA 4028 Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229960004853 betadex Drugs 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000004382 Amylase Substances 0.000 description 3
- 108010065511 Amylases Proteins 0.000 description 3
- 102000013142 Amylases Human genes 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 235000019418 amylase Nutrition 0.000 description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical group OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- CXBFZYKAVCAPSV-UHFFFAOYSA-N 1-(4-iodobenzoyl)-5-methoxy-2-methyl indole-3-acetic acid Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(I)C=C1 CXBFZYKAVCAPSV-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- QSESWLKFTMBIPZ-UHFFFAOYSA-N 4'-O-glucosyl-beta-gentiobiose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OCC2C(C(O)C(O)C(O)O2)O)C(O)C1O QSESWLKFTMBIPZ-UHFFFAOYSA-N 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000770536 Bacillus thermophilus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- FPBCRLIOSBQLHS-QVTSYAGHSA-N Isomaltosylmaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)O1 FPBCRLIOSBQLHS-QVTSYAGHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000203775 Thermoactinomyces Species 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- FOMCONPAMXXLBX-MQHGYYCBSA-N isopanose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H](O)[C@H]([C@H](O)[C@@H](O)C=O)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOMCONPAMXXLBX-MQHGYYCBSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 125000003071 maltose group Chemical group 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 102220201851 rs143406017 Human genes 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000009633 stab culture Methods 0.000 description 1
- -1 starch Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
【0001】[0001]
【産業上の利用分野】この発明は、多糖体プルラン及び
でん粉のα−1,4およびα−1,6グルコシド結合を
切断する能力をもつネオプルラナーゼ(本願においてネ
オプルラナーゼとは、後述する通り、バチルスサーモフ
イルスTRS40が生産するプルラナーゼ類似の酵素を
いう)をコードするDNA断片を有するプラスミドを使
ってネオプルラナーゼを効率よく製造する方法に関する
ものである。This invention relates to a neopullulanase having the ability to cleave the α-1,4 and α-1,6 glucoside bonds of the polysaccharide pullulan and starch (in the present application, neopullulanase is The present invention relates to a method for efficiently producing neopullulanase using a plasmid having a DNA fragment encoding a pullulanase-like enzyme produced by Bacillus thermophilus TRS40.
【0002】[0002]
【従来の技術および本発明が解決しようとする問題点】
従来、プルランに作用する酵素としては、プルランの末
端からグルコース単位で作用するグルコアミラーゼ、α
−1,6グルコシド結合だけを切断するプルラナーゼ、
プルラン中のα−1,4グルコシド結合を切断しイソパ
ノースを与えるイソプルラナーゼ、パノース(62 −α
−Glucosyl maltose)を生成するサー
モアクチノミセス ヴルガリカス(Thermoactinomyces
vulgaricus) のアミラーゼ(TVA)などが知られてい
る。[Prior Art and Problems to be Solved by the Present Invention]
Conventionally, as the enzyme acting on pullulan, glucoamylase, which acts on glucose unit from the end of pullulan, α
A pullulanase that cleaves only 1,6-glucosidic bonds,
Isopururanaze give isopanose cleaves alpha-l, 4-glucosidic bonds in pullulan, panose (6 2-.alpha.
-Glucosyl maltose-producing Thermoactinomyces
Amylase (TVA) of vulgaricus) is known.
【0003】本発明の酵素はプルランに作用してパノー
スを生成する点ではTVAと同様であるが、同時に本酵
素はグルコース、マルトースを生成する点で全くTVA
と異り、新しい作用特異性をもつ新規酵素である。また
本酵素はでん粉にも作用しα−アミラーゼの一種ともい
える。α−アミラーゼはでん粉糖化産業などにおいて広
く用いられる酵素であるので、本酵素単独乃至は他の各
種酵素と混合使用することにより色々な用途が開発され
るものと期待される。The enzyme of the present invention is similar to TVA in that it acts on pullulan to produce panose, but at the same time, the enzyme is completely TVA in that it produces glucose and maltose.
It is a novel enzyme with a new action specificity. This enzyme also acts on starch and can be said to be a type of α-amylase. Since α-amylase is an enzyme widely used in the starch saccharification industry and the like, it is expected that various uses will be developed by using this enzyme alone or in combination with other various enzymes.
【0004】[0004]
【問題点を解決するための手段および作用】本発明は新
規なプラスミドを有する枯草菌を利用して耐熱性のネオ
プルラナーゼを製造する方法に関するものである。The present invention relates to a method for producing thermostable neopullulanase using Bacillus subtilis having a novel plasmid.
【0005】本発明者等は、プルランを分解し主として
パノースを生成する耐熱性のあるネオプルラナーゼを分
泌するバチルス ステアロサーモフイルスTRS40を
大阪市鶴見区の堆肥より分離したのであるが、本酵素は
従来報告されているどのプルラナーゼともその活性が異
っており、本発明者等によってネオプルラナーゼと命名
された酵素である。なお、バチルス ステアロサーモフ
イルスTRS40は次のような菌学的性質を有してい
る。The present inventors separated Bacillus stearothermophilus TRS40, which secretes a thermostable neopullulanase that decomposes pullulan and mainly produces panose, from compost in Tsurumi-ku, Osaka City. The activity is different from any previously reported pullulanase, and it is an enzyme named neopullulanase by the present inventors. Bacillus stearothermophilus TRS40 has the following mycological properties.
【0006】一、形態学的性質 1)細胞の形及び大きさ……(0.6〜1.0)×(2
〜3.5)μの桿菌。連鎖性なく莢膜は少い。加糖肉汁
寒天培地では肉汁寒天培地と同一の桿菌の形を示す。 2)運動性……あり。 3)胞子……(0.4〜0.5)×(0.5〜0.6)
μの長円形で末端付近に存在し膜壁はうすい。60℃・
16時間で形成するものが多い。胞子のうのふくらみは
認められる。 4)グラム染色性……陽性。1. Morphological properties 1) Cell shape and size (0.6-1.0) × (2
~ 3.5) μ bacilli. There are few chains with no linkage. The sweetened broth agar shows the same bacillus form as the broth agar. 2) Motility ... Yes. 3) Spores ... (0.4 to 0.5) x (0.5 to 0.6)
It has an oval shape of μ, exists near the end, and has a thin membrane wall. 60 ° C
Many are formed in 16 hours. Swelling of the sporangium is observed. 4) Gram stainability: Positive.
【0007】二、生育状態 1)肉汁寒天平板培養……生育良好。表面はやや乾き白
色に近い。 2)肉汁寒天斜面培養……拡布状となり表面の光沢な
し。 3)肉汁液体培養……PH7.0で生育良好。液は混濁
する。 4)ゼラチン穿刺培養……ゼラチンを液化する。 5)食塩肉汁液体培養……7%の食塩水濃度では生育し
ない。 6)グルコース・アスパラギン寒天培地……生育不良。 7)グルコース・ナイトレイト寒天培地……僅かに生
育。2. Growth condition 1) Meat broth agar plate culture: Good growth. The surface is slightly dry and white. 2) Meat broth agar slope culture: Spreading and no surface gloss. 3) Liquid culture of broth .... Good growth at pH 7.0. The liquid becomes cloudy. 4) Gelatin stab culture: liquefy gelatin. 5) Salt broth liquid culture: Does not grow at 7% saline concentration. 6) Glucose / asparagine agar medium: poor growth. 7) Glucose / Nitrate agar medium ... Slightly grown.
【0008】三、生理学的性質 1)硝酸塩の還元……陽性。 2)でん粉の加水分解……でん粉を含むシヤーレ上で生
育させるときヨード呈色は陰性。 3)クエン酸の醗酵性……陽性。 4)カタラーゼの生成……陰性。 5)生育の範囲……トリプシン、酵母エキス、食塩を含
む培地で65℃まで生育。最適生育温度は60℃。 6)糖の醗酵性……グルコース、ラクトース、しょ糖か
ら酸を形成。ただし、ガス発生を伴わない。 7)アセチルメチルカルビノールの生成……陽性。 8)ゼラチンの分解……陽性。3. Physiological properties 1) Reduction of nitrate: Positive. 2) Hydrolysis of starch ... Iodine coloration is negative when grown on sialet containing starch. 3) Fermentability of citric acid: Positive. 4) Catalase production: Negative. 5) Growth range: Grow up to 65 ° C in a medium containing trypsin, yeast extract, and salt. The optimum growth temperature is 60 ° C. 6) Fermentability of sugar: An acid is formed from glucose, lactose and sucrose. However, no gas is generated. 7) Acetylmethylcarbinol formation: Positive. 8) Degradation of gelatin: Positive.
【0009】以上の結果をバージエーのマニアル・オブ
・システマテイック・バクテリオデターミネーション第
2巻(Bergey's Manual of Systematic Bacteriodeterm
ination vol 2.(1986)) と照合して本菌はバチルス ス
テアロサーモフイルス(Bacillus stearothermophilus)
と同定した。[0009] The above results are based on Bargey's Manual of Systematic Bacteriodeterm, Volume 2 of the Manual of Systematic Bacteriotermination.
ination vol 2. (1986)), this bacterium is Bacillus stearothermophilus
Was identified.
【0010】つぎに本菌株の生産する酵素を詳細に説明
する。 一、作用及び基質特異性 本酵素はプルランに作用し、最終的にパノース、グルコ
ース、マルトースを生じる。量的にはパノースが最も多
い。Next, the enzyme produced by this strain will be described in detail. 1. Action and substrate specificity This enzyme acts on pullulan and finally produces panose, glucose and maltose. In terms of quantity, panose is the most common.
【0011】でん粉に作用させると主としてマルトース
とグルコースを生じるが、反応後期には分枝デキストリ
ンとしてパノース及びイソマルトシルマルトース(isom
altosyl maltose 略称IMM)を生成する。還元糖の生
成に較べてヨード呈色の減少が速かでα−アミラーゼの
一種と考えられる。一般にα−アミラーゼは比較的でん
粉をよく加水分解する糖化型と、でん粉の液化速度は大
きいが糖化度の低い液化型に大別される。そして、前者
をでん粉に作用させた場合、得られる最小の低分子リミ
ットデキストリンはIMMである。本発明の酵素はでん
粉に作用させると最初からグルコースやマルトースを生
成し、糖化型のグループに属するが、最小のリミットデ
キストリンはIMMではなくパノースである。この点に
おいて著だ特異なα−アミラーゼである。更に、本酵素
はプルランとでん粉に同濃度、同条件で作用させると、
プルランに対してでん粉に対すると同等もしくはそれ以
上に作用する。TVAはでん粉への作用の方がプルラン
への作用より著しく大きい。この意味でTVAはα−ア
ミラーゼの一種と考えられるのに対し、本酵素はプルラ
ナーゼの一種であり、これを従来のプルラナーゼと区別
するため、ネオプルラナーゼと命名した。When starch is acted on, maltose and glucose are mainly produced, but in the latter stage of the reaction, panose and isomaltosyl maltose (isom) as branched dextrins are produced.
altosyl maltose (abbreviation IMM) is generated. It is considered to be a kind of α-amylase, because the iodine coloration decreases more rapidly than the production of reducing sugars. Generally, α-amylase is roughly classified into a saccharified type that hydrolyzes starch relatively well and a liquefied type that has a high starch liquefaction rate but a low saccharification degree. And, when the former is allowed to act on starch, the minimum low molecular weight limit dextrin obtained is IMM. The enzyme of the present invention produces glucose and maltose from the beginning when it acts on starch, and belongs to a saccharified group, but the minimum limit dextrin is panose rather than IMM. In this respect, it is a unique α-amylase. Furthermore, when this enzyme acts on pullulan and starch at the same concentration and under the same conditions,
Works as well or better on pullulan as on starch. TVA has a significantly greater effect on starch than on pullulan. In this sense, TVA is considered as a type of α-amylase, whereas this enzyme is a type of pullulanase, and was named neopullulanase to distinguish it from conventional pullulanase.
【0012】また、本酵素をβ−サイクロデキストリン
にマルトースがα−1,6グルコシル結合で結合したマ
ルトシル−β−サイクロデキストリンに作用させると、
まずそのα−1,6結合を切断し、マルトースとβ−サ
イクロデキストリンを生じる。ついでβ−サイクロデキ
ストリンも再分解を受け、グルコース、マルトース及び
マルトトリオースを与える。Further, when the present enzyme acts on maltosyl-β-cyclodextrin in which maltose is bound to β-cyclodextrin through α-1,6 glucosyl bond,
First, the α-1,6 bond is cleaved to produce maltose and β-cyclodextrin. The β-cyclodextrin then undergoes re-degradation to give glucose, maltose and maltotriose.
【0013】即ち、本酵素は主としてマルトースを認識
し、マルトースがα−1,4結合で結合していてもα−
1,6結合で結合していても、その結合を切断する新し
い作用特異性をもつ酵素と考えることができる。That is, this enzyme mainly recognizes maltose, and even if maltose is bound by α-1,4 bond, α-
It can be considered as an enzyme having a new action specificity that cleaves the bond even if it is bound by 1,6 bond.
【0014】二、作用PH PH5.0〜7.5。測定は0.05M酢酸ナトリウム
−酢酸緩衝液(PH4〜6)又はリン酸2ナトリウム−
リン酸1カリウム緩衝液(PH6〜8)を用い、0.5
%プルラン中で60℃、15分間反応させる。生成した
還元糖はDNS法で測定。2. Action PH PH 5.0 to 7.5. The measurement is 0.05 M sodium acetate-acetic acid buffer (PH4 to 6) or disodium phosphate-
Using a 1 potassium phosphate buffer (PH6-8), 0.5
% Reaction in pullulan at 60 ° C. for 15 minutes. The reducing sugar produced is measured by the DNS method.
【0015】三、作用最適PH 前記二の条件でおよそPH6.0。3. Optimum action PH Under the conditions of the above two, approximately PH 6.0.
【0016】四、作用温度 0.1Mリン酸緩衝液(PH6.0)、0.5%プルラ
ン中で各種温度下15分間反応させたところ、75℃ま
で反応した。4. Working temperature In 0.1 M phosphate buffer (PH 6.0) and 0.5% pullulan, the reaction was carried out at various temperatures for 15 minutes, and the reaction was carried out up to 75 ° C.
【0017】五、作用最適温度 前記の条件下60〜65℃であった。V. Optimum temperature of action 60 to 65 ° C. under the above conditions.
【0018】六、熱安定性 0.2M酢酸緩衝液(PH6.0)中で各種温度で60
分間加熱し残存活性を測定したところ、65℃において
60%の活性が残存していた。更にこの系に1mM,E
DTAを加えると90%以上活性は残存した。6. Thermostability 60 at various temperatures in 0.2M acetate buffer (PH 6.0)
When it was heated for minutes and the residual activity was measured, 60% of the activity remained at 65 ° C. Furthermore, 1 mM, E
When DTA was added, 90% or more of the activity remained.
【0019】七、PH安定性 PH5.5より9.0の間で安定(各種緩衝液を用いP
Hを調整し、60℃・60分放置後、PH7.0に調整
し残存活性を測定した)。7. PH stability Stable between pH 5.5 and 9.0 (P using various buffers
After adjusting H and leaving it at 60 ° C. for 60 minutes, it was adjusted to pH 7.0 and the residual activity was measured).
【0020】八、精製方法 培養上澄液を硫安分画(35〜60%飽和)した後、沈
でん物を少量の水に溶解し透析後、PH8.0でDEA
E−celluloseに吸着させた。ついで食塩濃度
を0.6Mまで漸次上昇させて酵素を溶出した。さらに
セフアデックスG−200のカラムクロマトグラフィー
を2回繰返した後、α−サイクロデキストリンを結合し
たセフアロース6B(Sepharose 6B) カラムでアフイニ
テイクロマトグラフイを行った。(8) Purification method After the culture supernatant was subjected to ammonium sulfate fractionation (35-60% saturation), the precipitate was dissolved in a small amount of water, dialyzed, and then DEA at pH 8.0.
Adsorbed on E-cellulose. Then, the salt concentration was gradually increased to 0.6 M to elute the enzyme. Further, column chromatography of Sephadex G-200 was repeated twice, and then affinity chromatography was carried out using a Sepharose 6B column to which α-cyclodextrin was bound.
【0021】溶出液の蛋白質の吸収は1個のピークを示
し、酵素活性のピークと完全に一致した。この活性区分
をSDS−PAGEにより電気泳動を行うと単一バンド
を示した。The protein absorption of the eluate showed one peak, which was completely in agreement with the peak of enzyme activity. Electrophoresis of this active fraction by SDS-PAGE showed a single band.
【0022】九、分子量 62000dalton(SDS−PAGE法)9, molecular weight 62000 dalton (SDS-PAGE method)
【0023】十、生産物 プルランからはパノースの他グルコース、マルトースを
与えた。また、でん粉からグルコース、マルトース、パ
ノース、IMMを与えた。(10) Products Glucose and maltose as well as panose were given from pullulan. Also, glucose, maltose, panose, and IMM were given from starch.
【0024】十一、力価測定方法 1%プルラン(0.2M酢酸緩衝液(PH6.0)に溶
解)0.25mlに酵素液0.25mlを加え、60℃
・15分間反応させ、生ずる還元力の増加をDNS法に
より定量した。上記反応で1分間当り1μmolの還元
糖を生ずる酵素力を1単位とした。Eleven, 0.25 ml of enzyme solution was added to 0.25 ml of 1% pullulan (dissolved in 0.2 M acetate buffer (PH 6.0)) at 60 ° C.
-The reaction was carried out for 15 minutes, and the resulting increase in reducing power was quantified by the DNS method. In the above reaction, the enzyme power to generate 1 μmol of reducing sugar per minute was defined as 1 unit.
【0025】以上の理化学的性質から、本発明酵素はこ
れまでに報告されたことのない新規なプルラナーゼであ
るといえる。From the above physicochemical properties, it can be said that the enzyme of the present invention is a novel pullulanase that has never been reported.
【0026】本発明では、かかる耐熱性のあるネオプル
ラナーゼの遺伝子をバチルス ステアロサーモフイル
ス、殊にバチルス ステアロサーモフイルスTRS40
から調製し、制限酵素ヒンドIII を用いて切断する。ヒ
ンドIII を使用するのは、酵素の分子量の大きさ、生成
蛋白質の細胞外への分泌に必要なキヤリアー蛋白質に相
当する遺伝情報(シグナル配列)などを有効に保持した
遺伝子の断片が得られるためである。切断処理法は常法
による。In the present invention, the thermostable neopullulanase gene is expressed in Bacillus stearothermophilus, particularly Bacillus stearothermophilus TRS40.
Cleaved with the restriction enzyme Hind III. Hind III is used because it gives a fragment of a gene that effectively retains the molecular weight of the enzyme and the genetic information (signal sequence) corresponding to the carrier protein required for extracellular secretion of the produced protein. Is. The cutting method is a conventional method.
【0027】切断した断片をショットガン方式でペクタ
ープラスミド、たとえばpTB522(Journal of Gen
eral Microbiology 、第131巻、第1757頁、19
85年刊行に記載あり)に組換え、枯草菌を宿主として
複製維持できる組換えプラスミドを作成する。目的とす
るプラスミドは、分子量約2.2Mdで制限酵素Eco
RIに対する切断箇所が2ケ所であり、EcoRIで処
理したときのDNA断片の分子量が0.8、0.4及び
1.0(Md)で示されうるDNA断片を含む組換えプ
ラスミドである。さらに具体的には、該DNA断片を前
記pTB522に組込み、本発明者等によってpPP1
0と命名された組換えプラスミドは、遺伝子工学的一般
的な手法により目的物質生産を可能とするための所望性
質(コピー数、薬剤耐性の種類、各種制限酵素の切断箇
所など)を有する。このプラスミドpPP10の制限酵
素地図は添付の図1に示す。The cleaved fragments are shotgun in a pecter plasmid such as pTB522 (Journal of Gen).
eral Microbiology 131, 1757, 19
(Described in 1985), and prepare a recombinant plasmid that can be replicated and maintained using Bacillus subtilis as a host. The target plasmid has a molecular weight of about 2.2 Md and a restriction enzyme Eco.
It is a recombinant plasmid containing two DNA cleavage sites and DNA fragments having molecular weights of 0.8, 0.4 and 1.0 (Md) when treated with EcoRI. More specifically, the DNA fragment was incorporated into the pTB522, and the present inventors et al.
The recombinant plasmid designated as 0 has the desired properties (copy number, type of drug resistance, cleavage sites of various restriction enzymes, etc.) to enable production of the target substance by a general genetic engineering technique. The restriction map of this plasmid pPP10 is shown in the attached FIG.
【0028】前述の組換えプラスミドで形質転換せしめ
た宿主枯草菌はアミラーゼ生産能を失った枯草菌であれ
ば菌株の如何を問わず利用できる。かかる欠損株は常法
により容易に取得できる。The host Bacillus subtilis transformed with the above-mentioned recombinant plasmid may be any strain of Bacillus subtilis that has lost the amylase-producing ability. Such a defective strain can be easily obtained by a conventional method.
【0029】本発明は枯草菌を使用したネオプルラナー
ゼの製造法に関するものである。即ち、組換えDNAを
維持する菌が生育しうる栄養培地として、たとえば炭素
源としてでん粉、可溶性でん粉、デキストリン、酸処理
でん粉などの炭水化物を1〜10%、窒素源として大豆
粕、大豆粕抽出物、乾燥酵母、ミルクカゼイン、ペプト
ン、肉エキス、コーンステイープリカー、ペプチド含有
物、アミノ酸類の単独ないし適宜の混和物を添加し、そ
の他必要に応じて少量の無機塩類を適量添加したものを
使い、これに菌体を接種し、PH6.5〜7.3、37
℃で24〜72時間通気攪拌培養することにより、ネオ
プルラナーゼを生育蓄積せしめるのである。この培養物
からネオプルラナーゼを回収・精製するには、培養濾液
を硫安により分画・沈でん、アルコール沈でん、膜濃縮
法などの通常の手段によって行えばよい。The present invention relates to a method for producing neopullulanase using Bacillus subtilis. That is, as a nutrient medium in which a bacterium that maintains recombinant DNA can grow, for example, 1 to 10% of carbohydrates such as starch, soluble starch, dextrin, and acid-treated starch as a carbon source, soybean meal as a nitrogen source, soybean meal extract , Dry yeast, milk casein, peptone, meat extract, corn stay liquor, peptide-containing substances, amino acids alone or an appropriate admixture are added, and if necessary, a small amount of inorganic salts is added in an appropriate amount. , Inoculated with the bacterial cells, PH 6.5-7.3, 37
Neopullulanase is allowed to grow and accumulate by agitating and culturing at a temperature of 24 to 72 hours. In order to recover and purify neopullulanase from this culture, the culture filtrate may be subjected to ordinary means such as fractionation / precipitation with ammonium sulfate, alcohol precipitation, and membrane concentration method.
【0030】[0030]
【実施例】 実施例1(組換えプラスミドの生成と形質転換された枯
草菌の培養) まずバチルス ステアロサーモフイルスTRS40の染
色体DNAを以下により調製する。Example 1 Production of recombinant plasmid and cultivation of transformed Bacillus subtilis First, chromosomal DNA of Bacillus stearothermophilus TRS40 is prepared as follows.
【0031】バチルス ステアロサーモフイルスTRS
40を100mlL培地を含む500ml容フラスコ中
で一夜、60℃で培養した。これを遠心集菌し、20m
lのTE緩衝液(10mMトリス、1mM・EDTA、
PH8.5)で洗浄し、3mlの15%しよ糖−50m
Mトリス(PH8.5)−50M・EDTA−1mg/
mlリゾチームに懸濁し、氷中で30分間静置した。こ
れに3mlの1%ザルコシル−50mMトリス(PH
8.5)−50mM・EDTAを添加し、混合した。つ
いで5.4gCsClを加え0.3mlのエチジウムブ
ロマイド液(10mg/ml)を加え、RP65Tロー
ター(日立製作所製)で超遠心場で分離した。超遠心終
了後、DNA区分を注射針で抜き取り、n−ブタノール
で3回抽出を繰り返してエチジウムブロマイドを除去し
た。このDNA試料を10mMトリス(PH7.5)−
0.1mM・EDTA中で透析し4℃で保存した。Bacillus stearothermophilus TRS
40 was cultured overnight at 60 ° C. in a 500 ml flask containing 100 ml L medium. Collect this by centrifugation, 20m
l TE buffer (10 mM Tris, 1 mM EDTA,
Washed with PH 8.5), 3 ml of 15% sucrose-50 m
M Tris (PH8.5) -50M EDTA-1mg /
It was suspended in ml lysozyme and allowed to stand in ice for 30 minutes. Add 3 ml of 1% sarcosyl-50 mM Tris (PH
8.5) -50 mM EDTA was added and mixed. Then, 5.4 g CsCl was added, 0.3 ml of ethidium bromide solution (10 mg / ml) was added, and the mixture was separated in an ultracentrifuge with an RP65T rotor (manufactured by Hitachi Ltd.). After the ultracentrifugation was completed, the DNA segment was extracted with an injection needle, and extraction with n-butanol was repeated 3 times to remove ethidium bromide. This DNA sample was treated with 10 mM Tris (PH7.5)-
It was dialyzed in 0.1 mM EDTA and stored at 4 ° C.
【0032】次いで以下の通りに制限酵素及びリガーゼ
で処理してベクタープラスミドを調製する。即ち、一方
では枯草菌を宿主として複製維持できるベクタープラス
ミドpTB522(テトラサイクリン耐性)を常法によ
り調製し、ついでバチルスステアロサーモフイルスTR
S40の染色体DNA及びpTB522を制限酵素ヒン
ドIII で切断する。その反応条件は次の通りである。Then, a vector plasmid is prepared by treating with restriction enzymes and ligase as follows. That is, on the other hand, a vector plasmid pTB522 (tetracycline resistance) capable of replicating and maintaining Bacillus subtilis as a host was prepared by a conventional method, and then Bacillus stearothermophilus TR
The chromosomal DNA of S40 and pTB522 are cut with the restriction enzyme Hind III. The reaction conditions are as follows.
【0033】 TRS40DNA 30μl 10×Hind III緩衝液 10μl (A) 牛血清アルブミン(5mg/ml) 2μl 水 56μl Hind III溶液 2μlTRS40 DNA 30 μl 10 × Hind III buffer 10 μl (A) Bovine serum albumin (5 mg / ml) 2 μl water 56 μl Hind III solution 2 μl
【0034】pTB522 10
μl 10×Hind III緩衝液 10μl (B) 牛血清アルブミン(5mg/ml) 2μl 水 76μl Hind III溶液 2μlPTB522 10
μl 10 × Hind III buffer 10 μl (B) Bovine serum albumin (5 mg / ml) 2 μl water 76 μl Hind III solution 2 μl
【0035】表中、10×Hind III緩衝液とは、1
00mMトリス(PH7.4)、100mMMgC
l2 、500mMNaCl、10mMジチオスレイトー
ルを含む。In the table, 10 × Hind III buffer means 1
00 mM Tris (PH7.4), 100 mM MgC
1 2 , 500 mM NaCl, 10 mM dithiothreitol.
【0036】上記溶液で37℃・1.5〜2時間反応さ
せる。上記で得られるA、B、2種類のDNAを混合
し、3M酢酸カリウム20μl加え、その後エタノール
0.45mlを加えて遠心し、上澄を除いた。沈でんは
エタノールで洗浄し、脱水・脱塩し、デシケーターで乾
燥した。この乾燥物に2×リガーゼ緩衝液(132mM
トリス(PH7.6)−13.2M・Mgcl2 )10
0μl、100mMジチオスレイトール20μl、5m
M・ATP20μl、水60μlを加え混合した後、D
NAリガーゼ1μlを加え、8℃・16時間保ち、DN
A溶液とした。The above solution is reacted at 37 ° C. for 1.5 to 2 hours. The two kinds of DNAs A and B obtained above were mixed, 20 μl of 3M potassium acetate was added, and then 0.45 ml of ethanol was added and centrifuged, and the supernatant was removed. The sediment was washed with ethanol, dehydrated and desalted, and dried in a desiccator. 2 x ligase buffer (132 mM
Tris (PH7.6) -13.2M · Mgcl 2) 10
0 μl, 100 mM dithiothreitol 20 μl, 5 m
After adding 20 μl of M.ATP and 60 μl of water and mixing, D
Add 1 μl of NA ligase and keep at 8 ° C for 16 hours.
A solution was used.
【0037】第3段階としては、上述のベクターを枯草
菌に導入してクローニングする段階である。The third step is the step of cloning by introducing the above vector into Bacillus subtilis.
【0038】バチルス ズブチリスNA1は、通常の変
異処理により得られるアミラーゼ欠損株の1つであるが
(日本農芸化学会昭和61年度京都大会にて発表。講演
番号2A−22)、これをL培地で一夜培養した後、そ
の1mlを100ml容フラスコ内のTFI培地20m
lに植菌する。Bacillus subtilis NA1 is one of the amylase-deficient strains obtained by ordinary mutation treatment (announced at the Kyoto Conference of the Japan Society for Agricultural Chemistry, 1986, Kyoto Conference, Lecture No. 2A-22), but this was used in L medium. After culturing overnight, 1 ml of the TFI medium in a 100 ml volumetric flask was added to 20 m.
inoculate l.
【0039】これを37℃で培養し、対数増殖期を外れ
てから1時間後、500ml容フラスコ内のTFII培地
36mlに4ml植菌し、1.5時間培養してコンピテ
ントセルを得る。This was cultured at 37 ° C., and 1 hour after the logarithmic growth phase was over, 4 ml of TFII medium in 36 ml of a 500 ml flask was inoculated and cultured for 1.5 hours to obtain competent cells.
【0040】TFI、TFII培地は夫々以下の通りであ
る。 The TFI and TFII media are as follows, respectively.
【0041】このコンピテント セル1mlに前述によ
り得られたDNA溶液を混合し、37℃・30分間激し
く振盪培養後、遠心集菌し、L培地1mlを加えて37
℃・1.5時間振盪培養する。その培養液を100μl
づつテトラサイクリン25μg/mlを含む寒天平板に
塗抹し、37℃1夜培養し、形質転換体を得た。1 ml of this competent cell was mixed with the DNA solution obtained above, and after vigorous shaking culture at 37 ° C. for 30 minutes, the cells were collected by centrifugation, and 1 ml of L medium was added to 37.
Incubate with shaking at 1.5 ° C for 1.5 hours. 100 μl of the culture
Each was spread on an agar plate containing 25 µg / ml of tetracycline and cultured overnight at 37 ° C to obtain a transformant.
【0042】この形質変換体をPLL寒天平板(1%プ
ルラン、0.2%トリプトン、0.2%イーストエキ
ス、0.2%Nacl、1.5%寒天(PH7.3))
にレプリカし、37℃1夜培養後、平板上にエタノール
を注ぎ数時間放置し、ハローを形成するコロニーを取得
した。このクローン株の保持する組換えプラスミドをp
PP10と命名した。This transformant was subjected to PLL agar plate (1% pullulan, 0.2% tryptone, 0.2% yeast extract, 0.2% Nacl, 1.5% agar (PH7.3)).
After culturing at 37 ° C. overnight, ethanol was poured onto the plate and left for several hours to obtain halo-forming colonies. The recombinant plasmid harbored by this clone strain was
It was named PP10.
【0043】実施例2(ネオプルラナーゼの製造) 実施例1により得られたpPP10を保持するバチルス
ズブチリスNA1を2.5%可溶性でん粉を含むL培
地(2.5μg/mlテトラサイクリン含有)にて37
℃・24時間培養した。培養液を遠心分離して上澄を採
り60℃・15分間加熱処理をした。この段階で培養上
澄液中の蛋白質は殆んど耐熱性のネオプルラナーゼのみ
であることが、SDSポリアクリルアミド電気泳動によ
り確認された。Example 2 (Production of neopullulanase) Bacillus subtilis NA1 retaining pPP10 obtained in Example 1 was cultured in L medium containing 2.5% soluble starch (containing 2.5 μg / ml tetracycline).
Culturing was carried out at a temperature of 24 hours. The culture solution was centrifuged and the supernatant was collected and heat-treated at 60 ° C for 15 minutes. At this stage, it was confirmed by SDS polyacrylamide electrophoresis that the protein in the culture supernatant was almost exclusively thermostable neopullulanase.
【0044】ネオプルラナーゼ活性測定法により関連菌
株を測定したところ、次のようであった。 When the related strains were measured by the neopullulanase activity measuring method, they were as follows.
【0045】組換えプラスミドpPP10を保持するバ
チルス ズブチリスNA1より得たネオプルラナーゼ
は、60℃、65℃で夫々60分間熱処理したところ、
夫々90%以上、60%程度の酵素活性を維持してお
り、耐熱性に富むことが確認された。Neopullulanase obtained from Bacillus subtilis NA1 carrying the recombinant plasmid pPP10 was heat treated at 60 ° C. and 65 ° C. for 60 minutes respectively,
It was confirmed that the enzyme activity was maintained at 90% or more and about 60% or more, respectively, and the heat resistance was excellent.
【0046】[0046]
【発明の効果】一般に好熱菌であるバチルス ステアロ
サーモフイルスは、枯草菌に較べ培養時の最終菌体濃度
が低く、菌体生産物を大量に取得するのが比較的困難で
ある。そこで本発明ではバチルス ステアロサーモフイ
ルス中の耐熱性酵素であるネオプルラナーゼの遺伝子を
枯草菌に組込むことにより、ネオプルラナーゼを大量に
取得することを可能としたものである。就中、バチルス
ステアロサーモフイルスTRS40のDNAをヒンド
III により処理して得られるDNA断片をpTB522
に組込んだバチルス ズブチリスNA1は本願発明を効
果的に実現可能とするものである。しかして本発明によ
るときは、宿主菌にα−アミラーゼ及びプロテアーゼ欠
損の変異株であるバチルス ズブチリスNA1を用いる
ので、培養濾液に含まれる菌体外分泌酵素は殆んど本菌
株にクローン化された耐熱性のネオプルラナーゼのみと
なり、その遺伝子が増幅されることにより、当該酵素の
生産性を顕著に向上せしめ得ることや、中温菌に好熱菌
の遺伝子がクローン化されたことにより、たとえば60
℃・15分間の加熱処理により培養濾液中の耐熱性のネ
オプルラナーゼ以外の蛋白質は殆んど変性沈でんしてし
まうことから、目的酵素の濃縮・精製はバチルス ステ
アロサーモフイルスTRS40を培養しこれから本件酵
素を濃縮・精製するよりも遙かに簡便・効率的に行うこ
とができる。EFFECTS OF THE INVENTION Generally, Bacillus stearothermophilus, which is a thermophilic bacterium, has a lower final cell concentration in culture than Bacillus subtilis, and it is relatively difficult to obtain a large amount of cell product. Therefore, in the present invention, a large amount of neopullulanase can be obtained by incorporating the gene of neopullulanase, which is a thermostable enzyme in Bacillus stearothermophilus, into Bacillus subtilis. In particular, hind the DNA of Bacillus stearothermophilus TRS40
The DNA fragment obtained by treatment with III was designated as pTB522.
The Bacillus subtilis NA1 incorporated in the present invention effectively realizes the present invention. However, according to the present invention, since Bacillus subtilis NA1 which is a mutant strain of α-amylase and protease deficiency is used as the host bacterium, most of the extracellular secretory enzyme contained in the culture filtrate is heat-resistant cloned in this strain. Since only the active neopullulanase is produced and the gene thereof is amplified, the productivity of the enzyme can be remarkably improved, and the thermophilic bacterium gene has been cloned into mesophilic bacterium.
Since proteins other than the thermostable neopullulanase in the culture filtrate are mostly denatured and precipitated by heat treatment at ℃ for 15 minutes, the target enzyme was concentrated and purified by culturing Bacillus stearothermophilus TRS40. It can be performed much more simply and efficiently than when the enzyme is concentrated and purified.
【0047】[0047]
【図1】ベクタープラスミドpTB522を用いて調製
した組換えプラスミドpPP10の制限酵素地図。図
中、太線で示した2.2MdのヒンドIII 断片に相当す
る部分は、バチルス ステアロサーモフイルスTRS4
0由来の耐熱性ネオプルラナーゼ遺伝子である。ただ
し、円内の数字は分子サイズをMdで表わしたもの。FIG. 1 is a restriction map of the recombinant plasmid pPP10 prepared using the vector plasmid pTB522. In the figure, the portion corresponding to the 2.2 Md Hind III fragment indicated by the bold line is Bacillus stearothermophilus TRS4.
0 is a thermostable neopullulanase gene. However, the numbers in the circle represent the molecular size in Md.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 (C12N 15/56 C12R 1:07) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI technical display location (C12N 15/56 C12R 1:07)
Claims (1)
cillus stearothermophilus)TRS40(微工研菌寄託
第9609号)の染色体DNAを制限酵素ヒンドIII
(Hind III)により処理して得られるネオプルラナ
ーゼをコードするDNA断片とヒンドIII で処理して得
られたベクター断片を結合させた分子量2.2Mdの組
換えDNAを複製維持した枯草菌を栄養培地で培養し、
その培養物からネオプルラナーゼを回収することを特徴
とする形質転換された枯草菌によるネオプルラナーゼの
製造法。1. Bacillus stearothermophilus (Ba
cillus stearothermophilus) TRS40 (Deposit No. 9609 of the Institute for Microbiology Research Institute) is a restriction enzyme hind III
(Hind III) -treated neopullulanase-encoding DNA fragment and the vector fragment obtained by treating with Hind III were ligated to Bacillus subtilis replicatively maintained with a recombinant DNA having a molecular weight of 2.2 Md. Cultured in
A method for producing neopullulanase by transformed Bacillus subtilis, which comprises recovering neopullulanase from the culture.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5085761A JPH0691818B2 (en) | 1987-12-25 | 1993-03-18 | Method for producing neopullulanase by transformed Bacillus subtilis |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33062587A JPH01171488A (en) | 1987-12-25 | 1987-12-25 | Recombinant plasmid, bacillus subtilis transformed therewith and production of pullulanase-analog enzyme using said bacillus |
| JP5085761A JPH0691818B2 (en) | 1987-12-25 | 1993-03-18 | Method for producing neopullulanase by transformed Bacillus subtilis |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP33062587A Division JPH01171488A (en) | 1987-12-25 | 1987-12-25 | Recombinant plasmid, bacillus subtilis transformed therewith and production of pullulanase-analog enzyme using said bacillus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH06121681A JPH06121681A (en) | 1994-05-06 |
| JPH0691818B2 true JPH0691818B2 (en) | 1994-11-16 |
Family
ID=26426766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5085761A Expired - Fee Related JPH0691818B2 (en) | 1987-12-25 | 1993-03-18 | Method for producing neopullulanase by transformed Bacillus subtilis |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0691818B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6053406B2 (en) * | 2012-09-13 | 2016-12-27 | 株式会社林原 | Novel α-glucan transferases, their production methods and uses |
-
1993
- 1993-03-18 JP JP5085761A patent/JPH0691818B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06121681A (en) | 1994-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1214407A (en) | Maltogenic amylase enzyme, preparation and use thereof | |
| NZ208420A (en) | Process for the production of a 3:2:1:3 glucan 1,4-alpha glucosidase | |
| JPH05508997A (en) | Novel thermostable pullulanase | |
| US4628028A (en) | Novel thermostable pullulanase enzyme and method for its production | |
| Kanlayakrit et al. | Characteristics of raw-starch-digesting glucoamylase from thermophilic Rhizomucor pusillus | |
| US4612287A (en) | Plasmids containing a gene coding for a thermostable pullulanase and pullulanase-producing strains of Escherichia coli and Bacillus subtilis containing the plasmids | |
| EP0258050A2 (en) | An amylase of a new type | |
| US5281527A (en) | Process for producing pullalanase | |
| CA1081633A (en) | Heat and acid-stable alpha-amylase enzymes and processes for producing the same | |
| JPH09173077A (en) | Ultra thermostable acid α-amylase and DNA fragment containing the α-amylase producing gene | |
| JP3173849B2 (en) | Novel debranching enzyme and method for producing the same | |
| JPH0691818B2 (en) | Method for producing neopullulanase by transformed Bacillus subtilis | |
| JPH0565157B2 (en) | ||
| JPH0515368A (en) | New pullulanase and production thereof | |
| JPS594119B2 (en) | Method for producing oligosaccharides using amylase G4,5 | |
| JPH0573388B2 (en) | ||
| JPS6331194B2 (en) | ||
| JPS6331195B2 (en) | ||
| JPS6342696A (en) | Production of sugar | |
| JPH10136979A (en) | Novel acidic alpha-amylase and its production | |
| JP2691354B2 (en) | Novel α-amylase, method for producing the same and method for producing saccharide using the same | |
| Saha et al. | Production and characteristics of an intracellular α-glucosidase from a color variant strain of Aureobasidium pullulans | |
| Cha et al. | Purification and Characterization of Bacillus Licheniformis $\alpha $-Amylase from Genetically Cloned E. coli NM522 | |
| JPS61115491A (en) | Heat-stable α-amylase and method for producing the same | |
| JPS61282073A (en) | Novel amylase, recombinant plasmid containing gene coding said amylase, microorganism transformed by said plasmid and production of novel amylase by said microorganism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |